Skip to the content

Home
About
Products
- Hezkue
- Upcoming Products
Pipeline
Investors
Careers
Contact

Michael Demurjian

Post author By Elliot Maza
Post date November 17, 2024

Home
About
Products
Pipeline
Investors
Careers
Contact

Search for:

Recent Posts

Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion
Aspargo Labs Appoints Chief Marketing Officer
Aspargo Labs Announces Data on First Oral Spray for Erectile Dysfunction, ASP-001, Showing Two Times Faster Absorption Compared to Viagra® Tablets
Aspargo Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study
Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension

Recent Comments

Archives

December 2024
November 2024
June 2024
December 2023
September 2023
August 2023
January 2023
November 2022
October 2022
September 2022
June 2022
May 2022
May 2020

Categories

Press Release

Meta

Log in
Entries feed
Comments feed
WordPress.org

Facebook-f X-twitter Instagram Linkedin

17 State Street, Suite 3220, New York, NY 10004 | 646-503-1260

© 2024 Aspargo Labs, Inc. All rights reserved. Privacy Policy.

Home
About
Products
Pipeline
Investors
Careers
Contact

Home
About
Products
Pipeline
Investors
Careers
Contact